Publicaciones en las que colabora con LUIS JAVIER MARTÍNEZ GONZÁLEZ (94)

2024

  1. Multi-omic study to unmask genes involved in prostate cancer development in a multi-case family

    Cancer Communications

2023

  1. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

    The Lancet, Vol. 401, Núm. 10374, pp. 347-356

  2. Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity

    Human Genomics, Vol. 17, Núm. 1

  3. Association of genetic polymorphisms in detoxifying systems and urinary metal(loid) levels with excess body weight among Spanish children: A proof-of-concept study

    Science of the Total Environment, Vol. 873

  4. Explainable artificial intelligence to predict and identify prostate cancer tissue by gene expression

    Computer Methods and Programs in Biomedicine, Vol. 240

  5. Follow-Up Biomarkers in the Evolution of Prostate Cancer, Levels of S100A4 as a Detector in Plasma

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

  6. Genetic Population Flows of Southeast Spain Revealed by STR Analysis

    Genealogy, Vol. 7, Núm. 2

  7. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome

    Biomedicine and Pharmacotherapy, Vol. 169

  8. Genetic variants of antioxidant and xenobiotic metabolizing enzymes and their association with prostate cancer: A meta-analysis and functional in silico analysis

    Science of the Total Environment, Vol. 898

2022

  1. Assessing the Impact of SARS-CoV-2 Lineages and Mutations on Patient Survival

    Viruses, Vol. 14, Núm. 9

  2. DNA isolation from human remains

    Handbook of DNA Profiling (Springer), pp. 755-771

  3. Determination of exosome mitochondrial dna as a biomarker of renal cancer aggressiveness

    Cancers, Vol. 14, Núm. 1

  4. Differences in maternal and neonatal cardiometabolic markers and placenta status by foetal sex. The GESTAFIT project

    Women's Health, Vol. 18

  5. Effects of genetic polymorphisms in body mass index according to dietary exposure to bisphenols and parabens

    Chemosphere, Vol. 293

  6. Estudio de la influencia de los polimorfismos rs9939609 FTO y rs9436303 LEPR en la variabilidad del índice de masa corporal

    Ars pharmaceutica, Vol. 63, Núm. 1, pp. 53-53

  7. Genetic Polymorphisms in VEGFR Coding Genes (FLT1/KDR) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients

    Pharmaceutics, Vol. 14, Núm. 8

  8. Genetic variants of antioxidant enzymes and environmental exposures as molecular biomarkers associated with the risk and aggressiveness of bladder cancer

    Science of the Total Environment, Vol. 843

  9. Interplay between genetics and lifestyle on pain susceptibility in women with fibromyalgia: The al-Ándalus project

    Rheumatology (United Kingdom), Vol. 61, Núm. 8, pp. 3180-3191

  10. Papel de las interacciones entre las variaciones genéticas y exposición dietética a contaminantes en la variabilidad interindividual del índice de masa corporal

    Ars pharmaceutica, Vol. 63, Núm. 1, pp. 51-52

  11. Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19

    Frontiers in Immunology, Vol. 13